These effects are not recapitulated by RB-005, suggesting that inhibition of ceramide synthase negates the beneficial effects of inhibiting SK1 activity on hypertrophy in PAH (Fig. 6). The gene discussed is TLCD3B; the disease is pulmonary arterial hypertension.